Companies:

 

Articles:

 

Biotech & Pharma

Cover Image for PharmAust trial heralds new era of hope for motor neurone disease patients

PharmAust trial heralds new era of hope for motor neurone disease patients

Cover Image for Imugene granted fast-track status for development of Vaxinia to treat bile duct cancers

Imugene granted fast-track status for development of Vaxinia to treat bile duct cancers

Cover Image for Chimeric Therapeutics reports positive in vitro data for CHM 1301 on pancreatic and ovarian cancers

Chimeric Therapeutics reports positive in vitro data for CHM 1301 on pancreatic and ovarian cancers

Cover Image for Algorae Pharmaceuticals partners with Monash University to expand cardiovascular drug development

Algorae Pharmaceuticals partners with Monash University to expand cardiovascular drug development

Cover Image for Neurotech International receives $3.17 million R&D tax incentive refund for treatment of paediatric neurological disorders

Neurotech International receives $3.17 million R&D tax incentive refund for treatment of paediatric neurological disorders

Cover Image for 4DMedical lung scan procedure to be included in US reimbursement program

4DMedical lung scan procedure to be included in US reimbursement program

Cover Image for Imugene doses first patient in US trial of Azer-cel allogeneic CAR T therapy

Imugene doses first patient in US trial of Azer-cel allogeneic CAR T therapy

Cover Image for Imugene reports positive early signals from Phase 1 trial of CF33-hNIS cancer killer

Imugene reports positive early signals from Phase 1 trial of CF33-hNIS cancer killer

Cover Image for Neuren Pharmaceuticals to receive significant royalties on back of DAYBUE sales surge

Neuren Pharmaceuticals to receive significant royalties on back of DAYBUE sales surge

Cover Image for Chimeric Therapeutics doses first patient in CHM 1101 Phase 1B trial to treat glioblastoma

Chimeric Therapeutics doses first patient in CHM 1101 Phase 1B trial to treat glioblastoma

Cover Image for Chimeric Therapeutics receives FDA clearance for CHM 2101 to treat gastrointestinal cancers

Chimeric Therapeutics receives FDA clearance for CHM 2101 to treat gastrointestinal cancers

Cover Image for Algorae Pharmaceuticals and UNSW join CSIRO’s Next Generation graduate program

Algorae Pharmaceuticals and UNSW join CSIRO’s Next Generation graduate program

Cover Image for PharmAust progresses MPL programs for treatment of motor neurone disease and canine oncology

PharmAust progresses MPL programs for treatment of motor neurone disease and canine oncology

Cover Image for Neurotech International accelerates specialist medical solutions for neurological disorders

Neurotech International accelerates specialist medical solutions for neurological disorders

Cover Image for Algorae Pharmaceuticals engages UNSW to establish AI platform for drug discovery

Algorae Pharmaceuticals engages UNSW to establish AI platform for drug discovery

Cover Image for Chimeric Therapeutics reports positive interim data from CLTX CAR T brain cancer trial

Chimeric Therapeutics reports positive interim data from CLTX CAR T brain cancer trial

Cover Image for Incannex Healthcare shareholders vote in favour of exclusive Nasdaq listing

Incannex Healthcare shareholders vote in favour of exclusive Nasdaq listing

Cover Image for InhaleRx submits ethics application for IRX616a to treat panic disorder

InhaleRx submits ethics application for IRX616a to treat panic disorder

Cover Image for Prescient Therapeutics to present latest cancer treatment breakthroughs at world-leading conference

Prescient Therapeutics to present latest cancer treatment breakthroughs at world-leading conference

Cover Image for Radiopharm Theranostics’ pancreatic cancer drug secures FDA nod for Phase 1 trial

Radiopharm Theranostics’ pancreatic cancer drug secures FDA nod for Phase 1 trial

Cover Image for PharmAust hits major milestone in motor neurone disease treatment study

PharmAust hits major milestone in motor neurone disease treatment study

Cover Image for Paradigm’s iPPS shown to reduce cartilage loss and improve function in osteoarthritis patients

Paradigm’s iPPS shown to reduce cartilage loss and improve function in osteoarthritis patients

Cover Image for Radiopharm receives approval for Phase 1 therapeutic study of NSCLC

Radiopharm receives approval for Phase 1 therapeutic study of NSCLC

Cover Image for PharmAust confirms strong data from Phase 2 study of monepantel to treat canine lymphoma

PharmAust confirms strong data from Phase 2 study of monepantel to treat canine lymphoma

Cover Image for Neurotech’s cannabinoid drug shows promise for treatment of PANDAS and PANS

Neurotech’s cannabinoid drug shows promise for treatment of PANDAS and PANS

Cover Image for Dimerix secures deal to commercialise DMX-200 for treatment of rare kidney disease

Dimerix secures deal to commercialise DMX-200 for treatment of rare kidney disease

Cover Image for Noxopharm granted FDA orphan drug status for CRO-67 to treat pancreatic cancer

Noxopharm granted FDA orphan drug status for CRO-67 to treat pancreatic cancer

Cover Image for ECS Botanics signs medicinal cannabis supply deal with MediCann Health

ECS Botanics signs medicinal cannabis supply deal with MediCann Health

Cover Image for Medtech firms assessing impact of proposed FDA regulation changes

Medtech firms assessing impact of proposed FDA regulation changes

Cover Image for US FDA transfers azer-cel IND application to Imugene

US FDA transfers azer-cel IND application to Imugene